-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Beam Therapeutics Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q2 2024.
- Beam Therapeutics Inc. Depreciation for the quarter ending June 30, 2024 was $5.58M, a 15.8% increase year-over-year.
- Beam Therapeutics Inc. Depreciation for the twelve months ending June 30, 2024 was $21.6M, a 27.7% increase year-over-year.
- Beam Therapeutics Inc. annual Depreciation for 2023 was $20M, a 42% increase from 2022.
- Beam Therapeutics Inc. annual Depreciation for 2022 was $14.1M, a 95.8% increase from 2021.
- Beam Therapeutics Inc. annual Depreciation for 2021 was $7.2M, a 52.1% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)